Currently out of the existing stock ratings of Robert Wasserman, 48 are a BUY (85.71%), 8 are a HOLD (14.29%).

Robert Wasserman

Work Performance Price Targets & Ratings Chart

Analyst Robert Wasserman, currently employed at BENCHMARK, carries an average stock price target met ratio of 22.98% that have a potential upside of 7.29% achieved within 31 days.

Robert Wasserman’s has documented 99 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on ABCL, Abcellera Biologics  at 20-Aug-2024.

Wall Street Analyst Robert Wasserman

Analyst best performing recommendations are on EBS (EMERGENT BIOSOLUTIONS).
The best stock recommendation documented was for EBS (EMERGENT BIOSOLUTIONS) at 4/11/2024. The price target of $5 was fulfilled within 32 days with a profit of $2.81 (128.31%) receiving and performance score of 40.1.

Average potential price target upside

AERC Aeroclean Technologies LLC DHR Danaher PRLB Proto Labs EBS Emergent Biosolutions IPA Immunoprecise Antibodies Ltd LGND Ligand Pharmaceuticals orporated ABCL Abcellera Biologics  CDXS Codexis HALO Halozyme Therapeutics RGEN Repligen TECH Bio-Techne Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.04 (257.14%)

2 years 2 months 18 days ago
(18-Aug-2022)

0/1 (0%)

$2.29 (48.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Robert Wasserman is most bullish on?

Potential upside of $19.69 has been obtained for TECH (BIO-TECHNE CORP)

Which stock is Robert Wasserman is most reserved on?

Potential downside of -$1.12 has been obtained for EBS (EMERGENT BIOSOLUTIONS)

What Year was the first public recommendation made by Robert Wasserman?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?